Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lemieszek, M. Golec, C. Reichel, J. Buczkowski, B. Mackiewicz, C. Skórska, A. Góra, J. Dutkiewicz, R. Ziesche, J. Milanowski (Lublin, Poland; Vienna, Austria). Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis. Eur Respir J 2013; 42: Suppl. 57, 5126

Member's Comments

No comment yet.

Related content which might interest you: Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Antimicrobial peptides in bronchoalveolar lavage in patients with chronic lung diseases Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis Source: International Congress 2014 – ILDs 5 Year: 2014 Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis Source: International Congress 2015 – IPF pathogenesis Year: 2015 Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid Source: International Congress 2014 – Translational studies in COPD Year: 2014 The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid Source: International Congress 2015 – IPF pathogenesis Year: 2015 Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007 Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016